Nanostructured Medical Devices: Regulatory Perspective and Current Applications

Area of Science:

• Materials Science
• Biomedical Engineering
• Regulatory Science

Background:

• Nanomaterials (NMs) are integral to modern medical device (MD) fabrication.
• The unique properties of NMs offer significant advantages but also pose potential risks.
• Established safety assessment methods may require adaptation for NMs due to potential accuracy issues.

Purpose of the Study:

• To explore the current applications of NMs in medical devices.
• To examine the regulatory landscape governing NMs in MDs, particularly European Regulation 2017/745.
• To highlight the safety considerations and challenges associated with NM-containing MDs.

Main Methods:

• Literature review of current NM applications in MDs.
• Analysis of regulatory documents, focusing on European Regulation 2017/745 (Rule 19).
• Discussion of methodological challenges in assessing NM biological effects, such as cytotoxicity.

Main Results:

• Nanostructured MDs are prevalent across various medical fields.
• European Regulation 2017/745 classifies MDs with NMs as Class III unless exposure is negligible.
• Standard toxicological assays may be compromised by NM presence, necessitating method validation.

Conclusions:

• Rigorous safety assessment is paramount for NM-containing MDs before market entry.
• Regulatory frameworks are evolving to address the specific risks of NMs in medical applications.
• Further research into validated testing methodologies for NM safety is crucial.